
Octride Depot 30mg Injection
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Octreotide acetate (30mg)
Overview Octride Depot 30mg Injection
Octreotide Depot 30mg Injection treats acromegaly, carcinoid tumors, and bleeding esophageal varices, and helps prevent post-pancreatic surgery complications. Administration is strictly by a healthcare provider; self-injection is unsafe. Dosage and frequency are determined solely by your physician. Consistent use is crucial for optimal results; discontinue only under medical guidance. Common side effects include diarrhea, abdominal pain, nausea, constipation, gas, and headache; report persistent or worsening symptoms. Pre-treatment disclosure of liver conditions and all other medications is essential.
Primary Ingredients of Octride Depot 30mg Injection
No information provided. A response cannot be generated.
Uses of Octride Depot 30mg Injection
Overgrowth of tissues (acromegaly)|Neuroendocrine tumors (carcinoids)|Esophageal vein rupture
Major Benefits of Octride Depot 30mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Octride Depot 30mg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Octride Depot 30mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Octride Depot 30mg Injection works:
Octreotide 30mg Depot Injection mimics somatostatin, a naturally occurring human hormone regulator. Its action suppresses the release of several hormones, including growth hormone, and reduces esophageal bleeding via vasoconstriction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Octride Depot 30mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Lanreotide 30mg injection for depot administration is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Sandostatin LAR 30mg injection is likely compatible with breastfeeding. Available human data indicates minimal infant risk associated with its use.
DrivingSAFE
Administering Octreotide Depot 30mg Injection typically does not impair driving ability.
KidneySAFE IF PRESCRIBED
Lanreotide Autogel 30mg injection presents no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
For individuals with hepatic impairment, administering Octride Depot 30mg Injection requires careful consideration. Dosage modification of Octride Depot 30mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Octride Depot 30mg Injection :
Should you forget a dose of Octride Depot 30mg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Octride Depot 30mg Injection
| Label | Value |
|---|---|
| Chemical Type | Somatostatin analogs |
| Developing Good Habits | No. |
| Type of Therapy | Endocrine Signals |
| Behavioral Class | Somatostatin receptor ligands |
